|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.15 EUR | -0.17% |
|
+2.41% | +35.39% |
| 07/07 | BAYER AG : JP Morgan gives a Neutral rating | ZD |
| 04/07 | BAYER AG : Goldman Sachs keeps its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAYER AG | Other Pharmaceuticals | -0.17% | +2.41% | +35.39% | -0.06% | -58.98% | 3.03TCr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition